why choose us

First received: June 05, 2023

Clinical Trial: Contribution of an Antiviral Drug (Valaciclovir) in the Treatment of Generalized Periodontitis (Stage III or IV and Grade A, B or C): Prospective, Randomized and Double Blind Clinical Trial

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Periodontitis Chronic Generalized Severe

Study Type: INTERVENTIONAL


Official Title: Contribution of an Antiviral Drug (Valaciclovir) in the Treatment of Generalized Periodontitis (Stage III or IV and Grade A, B or C): Prospective, Randomized and Double Blind Clinical Trial

Brief Summary: Periodontitis is an inflammatory pathology that destroys periodontitis and causes tooth loosening.Its high incidence, combined with very high oral and systemic morbidity, places this pathology at the heart of global public health priorities.The current therapeutic management of periodontitis is not satisfactory because it often leads to a stabilization of the disease, marked by frequent recurrences, especially severe forms.Improving the treatment of patients with periodontitis is therefore an essential priority.If…

Read more